Concordia Healthcare Corp. (NASDAQ:CXRX) shares were up 2.6% during trading on Wednesday . The stock traded as high as $9.46 and last traded at $9.18, with a volume of 1,122,385 shares. The stock had previously closed at $8.95.

Several research analysts recently commented on CXRX shares. Canaccord Genuity reaffirmed a “buy” rating on shares of Concordia Healthcare Corp. in a research note on Thursday, May 12th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $74.00 price target (down previously from $75.00) on shares of Concordia Healthcare Corp. in a research note on Tuesday, May 17th. Zacks Investment Research raised shares of Concordia Healthcare Corp. from a “sell” rating to a “hold” rating in a research note on Monday, May 30th. Goldman Sachs Group Inc. started coverage on shares of Concordia Healthcare Corp. in a research note on Monday, June 6th. They issued a “neutral” rating and a $32.00 price target on the stock. Finally, TD Securities reaffirmed a “buy” rating and issued a $37.00 price target (down previously from $45.00) on shares of Concordia Healthcare Corp. in a research note on Wednesday, June 29th. Two analysts have rated the stock with a sell rating, four have given a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $39.87.

The stock’s market cap is $455.84 million. The firm’s 50 day moving average price is $16.63 and its 200-day moving average price is $24.48.

Concordia Healthcare Corp. (NASDAQ:CXRX) last announced its quarterly earnings results on Friday, August 12th. The company reported $1.38 earnings per share for the quarter, meeting the consensus estimate of $1.38. The firm had revenue of $231.70 million for the quarter, compared to analyst estimates of $229.76 million. Concordia Healthcare Corp.’s revenue for the quarter was up 208.1% on a year-over-year basis. On average, equities analysts predict that Concordia Healthcare Corp. will post $5.35 earnings per share for the current fiscal year.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.